Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Diffuse large B-cell lymphoma can be classified by gene expression profiling into germinal center and activated B-cell subtypes with different prognoses after rituximab-CHOP. The importance of previously recognized prognostic markers, such as Bcl-2 protein expression and BCL2 gene abnormalities, has...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Visco, Carlo, Tzankov, Alexander, Xu-Monette, Zijun Y., Miranda, Roberto N., Tai, Yu Chuan, Li, Yan, Liu, Wei-min, d'Amore, Emanuele S. G., Li, Yong, Montes-Moreno, Santiago, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Wang, Huan-You, Dunphy, Cherie H., His, Eric D., Zhao, X. Frank, Choi, William WL., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Ai, Weiyun, O'Neill, Stacey, Ponzoni, Maurilio, Ferreri, Andres JM., Kahl, Brad S., Winter, Jane N., Go, Ronald S., Dirnhofer, Stephan, Piris, Miguel A., Møller, Michael B., Wu, Lin, Medeiros, L. Jeffrey, Young, Ken H.
Формат: Artigo
Язык:Inglês
Опубликовано: Ferrata Storti Foundation 2013
Предметы:
Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561433/
https://ncbi.nlm.nih.gov/pubmed/22929980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.066209
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы